Radioimmunotherapy (90Y-Ibritumomab Tiuxetan) for Posttransplant Lymphoproliferative Disorders After Prior Exposure to Rituximab
2015 ◽
Vol 15
(7)
◽
pp. 1976-1981
◽
2013 ◽
Vol 16
(2)
◽
pp. 67-73
◽
1998 ◽
Vol 30
(4)
◽
pp. 1118-1120
◽
2002 ◽
Vol 117
(1)
◽
pp. 24-28
◽
2004 ◽
Vol 121
(2)
◽
pp. 246-253
◽
1994 ◽
Vol 2
(2)
◽
pp. 105-115
◽
2018 ◽
Vol 43
(6)
◽
pp. 441-444
◽